These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38666406)

  • 21. Stakeholder engagement to ensure the sustainability of biobanks: a survey of potential users of biobank services.
    Klingler C; von Jagwitz-Biegnitz M; Baber R; Becker KF; Dahl E; Eibner C; Fuchs J; Groenewold MK; Hartung ML; Hummel M; Jahns R; Kirsten R; Kopfnagel V; Maushagen R; Nussbeck SY; Schoneberg A; Winter T; Specht C
    Eur J Hum Genet; 2022 Dec; 30(12):1344-1354. PubMed ID: 34031552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustainability of Biobanks in the Future.
    De Souza YG
    Adv Exp Med Biol; 2015; 864():29-35. PubMed ID: 26420611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What Do Biomedical Researchers Want from Biobanks? Results of an Online Survey.
    Rush A; Catchpoole DR; Reaiche-Miller G; Gilbert T; Ng W; Watson PH; Byrne JA
    Biopreserv Biobank; 2022 Jun; 20(3):271-282. PubMed ID: 34756100
    [No Abstract]   [Full Text] [Related]  

  • 24. The Significance of Biobanking in the Sustainability of Biomedical Research: A Review.
    Zohouri M; Ghaderi A
    Iran Biomed J; 2020 Jul; 24(4):206-13. PubMed ID: 32306718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ethical, legal and social issues publications on biobanks 2011-2018. A scoping review.].
    Argudo-Portal V; Domènech M
    Rev Esp Salud Publica; 2020 Jun; 94():. PubMed ID: 32581211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction of a business model to assure financial sustainability of biobanks.
    Warth R; Perren A
    Biopreserv Biobank; 2014 Dec; 12(6):389-94. PubMed ID: 25496150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The EuPA Biobank Initiative: Meeting the future challenges of biobanking in proteomics & systems medicine.
    Wheelock ÅM; Paulson L; Litton JE;
    J Proteomics; 2015 Sep; 127(Pt B):414-6. PubMed ID: 26216594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biospecimen Complexity and the Evolution of Biobanks.
    Hartman V; Matzke L; Watson PH
    Biopreserv Biobank; 2019 Jun; 17(3):264-270. PubMed ID: 31188632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transparency of Biobank Access in Canada: An Assessment of Industry Access and the Availability of Information on Access Policies and Resulting Research.
    Gibson SG; Axler RE; Lemmens T
    J Empir Res Hum Res Ethics; 2017 Dec; 12(5):310-325. PubMed ID: 28818009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenges and Driving Forces for Business Plans in Biobanking.
    Macheiner T; Huppertz B; Bayer M; Sargsyan K
    Biopreserv Biobank; 2017 Apr; 15(2):121-125. PubMed ID: 28338345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Taiwan Regulation of Biobanks.
    Fan CT; Hung TH; Yeh CK
    J Law Med Ethics; 2015; 43(4):816-26. PubMed ID: 26711420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Position Statement from the German Biobank Alliance on the Cooperation Between Academic Biobanks and Industry Partners.
    Baber R; Hummel M; Jahns R; von Jagwitz-Biegnitz M; Kirsten R; Klingler C; Nussbeck SY; Specht C
    Biopreserv Biobank; 2019 Aug; 17(4):372-374. PubMed ID: 31314575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biobank Finances: A Socio-Economic Analysis and Review.
    Gee S; Oliver R; Corfield J; Georghiou L; Yuille M
    Biopreserv Biobank; 2015 Dec; 13(6):435-51. PubMed ID: 26697914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positive association between research competitiveness of Chinese academic hospitals and the scale of their biobanks: A national survey.
    Zhang Y; Bian Z; Chen Y; Jiang E; Chen T; Wang C
    Clin Transl Sci; 2022 Dec; 15(12):2909-2917. PubMed ID: 36177952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The reported impact of public involvement in biobanks: A scoping review.
    Luna Puerta L; Kendall W; Davies B; Day S; Ward H
    Health Expect; 2020 Aug; 23(4):759-788. PubMed ID: 32378306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Plan for Academic Biobank Solvency-Leveraging Resources and Applying Business Processes to Improve Sustainability.
    Uzarski D; Burke J; Turner B; Vroom J; Short N
    Clin Transl Sci; 2015 Oct; 8(5):553-7. PubMed ID: 25996355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measuring the contribution of tumor biobanks to research in oncology: surrogate indicators and bibliographic output.
    Hofman V; Ilie M; Long E; Washetine K; Chabannon C; Figarella-Branger D; Clément B; Mabile L; Cambon-Thomsen A; Boucher P; Dagher G; Hewitt R; Parodi B; Hofman P
    Biopreserv Biobank; 2013 Aug; 11(4):235-44. PubMed ID: 24845591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How to Make a Cost Model for the Birth Cohort Biobank in China.
    Wu M; Wu D; Hu C; Yan C
    Front Public Health; 2020; 8():24. PubMed ID: 32154203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Next Chapter of the Taiwan Biobank: Sustainability and Perspectives.
    Lin JC; Chen LK; Hsiao WW; Fan CT; Ko ML
    Biopreserv Biobank; 2019 Apr; 17(2):189-197. PubMed ID: 30715914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Research Perspective on Utilizing and Valuing Tumor Biobanks.
    Rush A; Matzke L; Cooper S; Gedye C; Byrne JA; Watson PH
    Biopreserv Biobank; 2019 Jun; 17(3):219-229. PubMed ID: 30575428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.